UK awards £82.6m to AI drug discovery companies
The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive approach to AI.
Artificial Intelligence
The AI advantage in discovering new medicines
AI’s potential in women’s health exciting, says Gates Foundation leader
Pfizer believes in the metaverse: will healthcare thaw the technology’s winter?
JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic
Artificial intelligence and atopic dermatitis: A new era for disease management?
Digital transformation expected to shorten drug development timelines
Enveda raises $130m to advance AI-driven plant based drug development
